About CoTherix
CoTherix is a company based in San Francisco (United States) founded in 2000 was acquired by Actelion in November 2006.. CoTherix has raised $55 million across 1 funding round from investors including Actelion, Frazier Healthcare Partners and Thomas Weisel Partners. CoTherix operates in a competitive market with competitors including Actelion, Aerovate Therapeutics, Vivus, Centessa Pharmaceuticals and Biosion, among others.
- Headquarter San Francisco, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CoTherix
CoTherix has successfully raised a total of $55M through 1 strategic funding round. The most recent funding activity was a Series C round of $55 million completed in October 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series C — $55.0M
-
First Round
First Round
(14 Oct 2003)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2003 | Amount | Series C - CoTherix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CoTherix
CoTherix has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Actelion, Frazier Healthcare Partners and Thomas Weisel Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech funding, drug development support, and investment in life sciences.
|
Founded Year | Domain | Location | |
|
Healthcare sector private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on healthcare companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CoTherix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CoTherix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cotherix Comparisons
Competitors of CoTherix
CoTherix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Actelion, Aerovate Therapeutics, Vivus, Centessa Pharmaceuticals and Biosion, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Innovative treatments for orphan diseases are discovered, developed, and commercialized.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for pulmonary arterial hypertension are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for obesity and sexual health
|
|
| domain | founded_year | HQ Location |
Medicines for sleep-wake, neurological, neurodegenerative, and psychiatric disorders are developed.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics are developed for treating various diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cotherix
Frequently Asked Questions about CoTherix
When was CoTherix founded?
CoTherix was founded in 2000 and raised its 1st funding round 3 years after it was founded.
Where is CoTherix located?
CoTherix is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is CoTherix a funded company?
CoTherix is a funded company, having raised a total of $55M across 1 funding round to date. The company's 1st funding round was a Series C of $55M, raised on Oct 14, 2003.
What does CoTherix do?
CoTherix was established in 2000 in San Francisco, United States, within the biopharmaceutical sector. Therapeutics targeting cardiopulmonary and chronic diseases were licensed and developed by the company. Operations centered on inhaled treatments, including Ventavis (iloprost), approved for pulmonary arterial hypertension. The firm was acquired by Actellion in January 2007, concluding its independent activities.
Who are the top competitors of CoTherix?
CoTherix's top competitors include Aerovate Therapeutics, Actelion and Vivus.
Who are CoTherix's investors?
CoTherix has 9 investors. Key investors include Actelion, Frazier Healthcare Partners, Thomas Weisel Partners, Turmeric Acquisition Corp, and Sofinnova.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.